🔎 Trials Near Me

Dachaigh › Leukemia myeloid geur › New Jersey › Newark

Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an Newark, NJ

Tha 12 sgrùdaidhean airson Leukemia myeloid geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Newark (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

A’ fastadhÌre 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Morristown Medical Center, Morristown · 17 mìle air falbh
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mìle air falbh
Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mìle air falbh
Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

A’ fastadhÌre 3
  • Newark Beth Israel Medical Center, Newark
  • Morristown Medical Center, Morristown · 17 mìle air falbh
6 Months – 21 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04293562

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

A’ fastadhÌre 1/2
  • Atlantic Health, Morristown · 17 mìle air falbh
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT04588922

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

A’ fastadhÌre 3
  • Morristown Medical Center, Morristown · 17 mìle air falbh
29 Days – 21 Years · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05183035

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

A’ fastadhÌre 2/3
  • Atlantic Health, Morristown · 17 mìle air falbh
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT06788756

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

A’ fastadhÌre 1/2
  • Atlantic Health, Morristown · 17 mìle air falbh
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT04988555

Sgrùdaidhean Leukemia myeloid geur ann am bailtean eile

Sgrùdaidhean eile ann an Newark

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.